Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-14

Clinical Trial Update: LEO 29102 Cream in the Treatment of Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial results for LEO 29102 Cream in atopic dermatitis have been posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEO 29102 Cream

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2019-10-14